https://www.selleckchem.com/pr....oducts/gilteritinib-
Notably, transplant outcomes (engraftment, acute graft-versus-host disease and non-relapse mortality) with cryopreserved products were comparable to those with fresh products. Considering that the emergency situation may persist for months, cryopreserving allogeneic grafts can offer a lifesaving opportunity for patients whose allogeneic transplant cannot be postponed until after the end of the COVID-19 pandemic. Considering that the emergency situation may persist for months, cryopreserving allogeneic grafts can offer a lif
Like
Comment
Share
